Citalopram No Better Than Placebo Treatment for Children with Autism Spectrum Disorders – 3
Narrator: This is NIH Health Matters. Recent study findings do not support using the drug citalopram to treat repetitive behaviors in children with autism spectrum disorders.
Dr. King: What we found was that citalopram and placebo did not distinguish themselves from one another.
Narrator: Dr. Bryan King is with the University of Washington and Seattle Children’s Hospital.
Dr. King: The other finding of interest is that side effects were more common in the children who received citalopram than in the placebo.
Narrator: But Dr. King clarifies that while citalopram did not work at treating repetitive behaviors in autism, the drug is useful for such behaviors in obsessive compulsive disorder. For details on the study, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Audio
NIH Audio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Audio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Audio is a service of the Office of Communications & Public Liaison.